Camilla Fridh

Camilla Fridh is an accomplished CMC Regulatory Affairs professional with extensive experience in the pharmaceutical industry. Currently serving as CMC Regulatory Affairs Director at Camurus since January 2021, Fridh has also held roles as Senior CMC Regulatory Affairs Manager and CMC Regulatory Affairs Manager at the same company. Prior to this, Fridh was RA Manager at PolyPeptide Lab from January 2014 to January 2021 and Development Engineer at QPharma AB from August 2012 to January 2014. Early career experience includes positions as Research Scientist in Late Stage Development at Ferring Pharmaceuticals and Senior Scientist Formulation at AstraZeneca R&D, where Fridh led inhaled project teams and coordinated formulation and manufacturing process development activities. Fridh’s educational background includes a Master's degree in Chemical Engineering from the Faculty of Engineering at Lund University and several additional qualifications from Linnaeus University and other institutions.